Education
About Us
Working with TipRanks
Follow Us
Electromed (ELMD)
XASE:ELMD
ELMD Stock Chart & Stats
$24.83
$0.65(2.15%)
At close: 4:00 PM EST
$24.83
$0.65(2.15%)
Day’s Range― - ―
52-Week Range$17.73 - $35.56
Previous CloseN/A
Volume34.94K
Average Volume (3M)50.45K
Market Cap
$240.21M
Enterprise Value$199.02M
Total Cash (Recent Filing)$14.11M
Total Debt (Recent Filing)$110.00K
Price to Earnings (P/E)30.9
Beta0.65
Next Earnings
Feb 17, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.25
Shares Outstanding8,340,538
10 Day Avg. Volume57,987
30 Day Avg. Volume50,452
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)4.24
Price to Sales (P/S)2.86
P/FCF Ratio16.53
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue3.01
Enterprise Value/Gross Profit3.85
Enterprise Value/Ebitda17.02
Forecast
1Y Price Target
$36.67Price Target Upside47.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market OpportunityA substantial opportunity remains within the diagnosed population, and, beyond this, ~4.0M people in the U.S. are estimated to have BE but are undiagnosed.
Productivity And Sales ForceThe sales force size and productivity guidance laid out by management are conservative, and a new CRM has been adopted, which should further boost productivity.
Revenue GrowthElectromed is expected to be able to post consistent double-digit revenue growth in the years to come and see operating leverage arising from the top line growth.
Bears Say
Electromed News
ELMD FAQ
What was Electromed’s price range in the past 12 months?
Electromed lowest stock price was $17.73 and its highest was $35.56 in the past 12 months.
What is Electromed’s market cap?
Electromed’s market cap is $240.21M.
When is Electromed’s upcoming earnings report date?
Electromed’s upcoming earnings report date is Feb 17, 2026 which is in 34 days.
How were Electromed’s earnings last quarter?
Electromed released its earnings results on Nov 12, 2025. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.205 by $0.045.
Is Electromed overvalued?
According to Wall Street analysts Electromed’s price is currently Undervalued.
Does Electromed pay dividends?
Electromed does not currently pay dividends.
What is Electromed’s EPS estimate?
Electromed’s EPS estimate is 0.26.
How many shares outstanding does Electromed have?
Electromed has 8,340,538 shares outstanding.
What happened to Electromed’s price movement after its last earnings report?
Electromed reported an EPS of $0.25 in its last earnings report, beating expectations of $0.205. Following the earnings report the stock price went up 3.822%.
Which hedge fund is a major shareholder of Electromed?
Currently, no hedge funds are holding shares in ELMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Electromed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$36.67 (47.68% Upside)
$36.67 (47.68% Upside)
Blogger Sentiment
Bullish
ELMD Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 10.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 11.1%
Last 30 Days ▼ 11.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.62%
12-Months-Change
Fundamentals
Return on Equity
19.02%
Trailing 12-Months
Asset Growth
9.61%
Trailing 12-Months
Company Description
Electromed
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
ELMD Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Electromed's earnings call presented a positive outlook with consistent revenue growth, strategic initiatives, and operational improvements. Despite challenges in hospital sales and a decrease in other revenue, the company's strong performance across multiple channels and strategic investments position it well for future success.View all ELMD earnings summariesELMD Stock 12 Month Forecast
Average Price Target
$36.67
▲(47.68% Upside)
Technical Analysis
Ownership Overview
7.16% Insiders
10.04% Mutual Funds
9.65% Other Institutional Investors
64.32% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---